The alfapump® system is not currently approved in the United States or Canada. In the United States and Canada, the alfapump® system is currently under clinical investigation (POSEIDON Study) and is being studied in adult patients with refractory or recurrent ascites due to cirrhosis. For more information regarding the POSEIDON clinical study see www.poseidonstudy.com.
The DSR therapy is still in development and it should be noted that any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed.
The DSR therapy is not currently approved for clinical research in the United States or Canada. There is no link between the DSR therapy and ongoing investigations with the alfapump® system in Europe.

Benefits of the alfapump®

We developed the alfapump® system to help patients suffering from refractory ascites avoid abdominal swelling and its accompanying complications. The alfapump® is a fully implantable battery-operated pump system that collects ascites as it forms and pumps it into the bladder, where it is excreted naturally through normal urination.

Key benefits

Back to your independent life

Helps patients to live a more normal life, freeing them from repeated hospital visits for paracentesis

More mobile and active

Patients feel better because they are no longer weighed down by large volumes of ascites and they become more mobile and active

Program your routine

Your doctor can program the alfapump® to meet your individual requirements and set it in accordance with your daily routine, for example to adapt to your work or sleeping pattern

Improves quality of life

Many doctors and patients have reported that the alfapump system helps improve quality of life, which we consider a giant leap forward